The emergence of some driver gene mutations during treatments was detected by circulating tumor DNA analysis, revealing mutations in RB1 and to a larger extent in PIK3CA and the ERα gene ESR1 itself [52, 53]. This evidence concerns the gene PIK3CA and neoplasm.